Skip to content
10-K

Annual Report

ENTERA BIO LTD. ENTX

0001178913-25-001112

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 20, 2025 45.42M sh
Shares Diluted FY 2024 · Dec 31, 2023 29.01M sh
Capex FY 2024 · Dec 31, 2023 $17K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$7.31M
Cash And Equivalents FY 2024 · Dec 31, 2023 $11.02M
Current Liabilities FY 2024 · Dec 31, 2023 $1.09M
Total Liabilities FY 2024 · Dec 31, 2023 $1.38M
Current Assets FY 2024 · Dec 31, 2023 $11.26M
Total Assets FY 2024 · Dec 31, 2023 $11.77M
Eps Diluted FY 2024 · Dec 31, 2023 $0.31
Eps Basic FY 2024 · Dec 31, 2023 $0.31
Rd Expense FY 2024 · Dec 31, 2023 $4.51M
Net Income FY 2024 · Dec 31, 2023 −$8.89M
Operating Income FY 2024 · Dec 31, 2023 −$8.89M
Gross Profit FY 2024 · Dec 31, 2023 $0
Cost Of Revenue FY 2024 · Dec 31, 2023 $0
Revenue FY 2024 · Dec 31, 2023 $0
Stockholders Equity FY 2024 · Dec 31, 2022 $11.75M